ACRV Kacepetan wutah bathi saben saham ing taun lumaku acrivon.com

Acrivon Therapeutics (ACRV) relies on a narrow-profile search for proteomic targets, which entails typical binary biotech risks. The creation of a precision oncology system allows for the integration of diagnostics into treatment, establishing a new standard of therapy. A competitive advantage is provided by AI-driven forecasting of patient responses. Comparable earnings per share growth compared to last year visualizes the EPS trend, where 8.30 shows the level of this metric.

Wutah bathi saben saham ing taun lumaku Acrivon (ACRV): kanggo periode 28.04.2023 - 15.11.2026

Rincian analitis lan laporan data perusahaan Acrivon Pharma (ACRV)

- nilai saham lan prakiraan konsensus rega:

Rega bursa Acrivon Pharma|ACRV - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar Acrivon Therapeutics Inc|ACRV - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data ekuitas miturut neraca:

Nilai Buku saben Saham Acrivon Therapeutics|ACRV - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Nilai Buku acrivon.com|ACRV - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Kabeh Utang marang Dana Pribadi Acrivon Therapeutics|ACRV - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Acrivon Therapeutics Inc|ACRV - Utang perusahaan|Rasio utang marang nilai buku Acrivon Therapeutics|ACRV - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Acrivon Therapeutics|Likuiditas darurat acrivon.com

- rincian bathi lan kelipatan pasar:

ACRV - Bathi resik perusahaan|Bathi sing dikarepake Acrivon Therapeutics|ACRV - Rasio rega marang bathi|Rasio prakiraan rega marang bathi Acrivon Therapeutics|ACRV - Pangali PEG|Pangali nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acrivon Therapeutics Inc|ACRV - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Acrivon Therapeutics|ACRV - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan acrivon.com|ACRV - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Acrivon Therapeutics

- data pendapatan lan penerimaan dodolan:

ACRV - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Acrivon|ACRV - Multiplikator P/S|Rasio kapitalisasi marang dodolan sing dikarepake Acrivon Therapeutics Inc|ACRV - Wutah pendapatan YoY sajrone 12 wulan kepungkur

Analisis dhasar perusahaan:Acrivon

The metric is calculated as the percentage deviation of current earnings per share from the same value last year. It measures the efficiency of net income capitalization, reflecting the growth rate of shareholder value. For Acrivon Therapeutics (ACRV), this indicator is sensitive to the success of the APAM platform and the progress of the ACR-368 drug. M&A potential could radically alter financial stability. The annual earnings per share trajectory visualizes these fundamental shifts.

Pesaing langsung

Kacepetan wutah bathi saben saham ing taun lumaku Novocure (NVCR)|Wutah bathi saben saham ing taun lumaku Alpha Tau Medical Ltd|Kacepetan wutah bathi saben saham ing taun lumaku Fortress Biotech FBIO|Wutah bathi resik saben saham ing taun iki ALLR (allarity.com)